Tiziana Life Sciences Ltd
Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.65
- 52-Week Range
- $0.55 – $1.90
- Market Cap
- $103.50M
- P/E (TTM)
- —
- EPS (TTM)
- -0.21
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- -780.60%
- Return on Assets
- -103.16%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 0.69
- Debt/Equity
- —
- Total Debt
- $932.00K
- Free Cash Flow
- $-6.38M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $101.25M
Market Snapshot
About
Tiziana Life Sciences Ltd is a biotechnology company focused on discovering and developing transformative therapies for cancer and immune-modulated inflammatory diseases. The company is advancing novel intranasal immunotherapies and other innovative treatments.